ArticleRevista da Escola de Enfermagem da U S P2025
Nutrition risk stratification and metabolic disorders in patients on parenteral nutrition.
Article in Revista da Escola de Enfermagem da U S P, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the association between metabolic disorders and death in patients receiving Parenteral Nutrition (PN), according to a proposal for stratification into nutri-tional risk groups, using the Nutritional Risk Screening, 2002 (NRS-2002).
methodA cohort with 84 patients receiving PN, with an NRS-2002 score of ≥3, classified into two subgroups: moderate risk (NRS 3-4) and severe risk (NRS 5-7). Secondary data from medical and nutritional records were used. The outcome variable was "presence of metabolic disorders and death"; and exposures: moderate and severe nutritional risk. Descriptive, bivariate analyses and logistic regression models were performed.
resultsNo difference was observed between the groups in terms of death. The adjusted RR (95% CI) for sodium disorders was 4.88 (1.5-16.2) (p = 0.009), and for magnesium disorders, 7.58 (2.33-24.6) (p = 0.001), being higher in the severe risk group.
conclusionThe stratification of the nutritional risk range into moderate and severe risk was able to identify patients at higher risk of developing metabolic disorders, especially sodium and magnesium ones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.